Company Filing History:
Years Active: 1978-1989
Title: Joseph W. Whalen: Innovator in Antibiotic Development
Introduction
Joseph W. Whalen is a notable inventor based in Midland, MI (US). He has made significant contributions to the field of antibiotic development, holding a total of 4 patents. His work focuses on innovative solutions for bacterial inhibition and animal health.
Latest Patents
Whalen's latest patents include Antibiotic A26201-1 and Antibiotic A26201-2, which are produced by the novel microorganism, Actinoplanes species A26201 (ATCC 39573). These antibiotics are particularly effective in inhibiting gram-positive bacteria and promoting the growth of monogastric and ruminant animals. Additionally, he has developed a method for treating swine dysentery through the administration of an animal feed composition containing an effective amount of an alkoxysilane compound, such as 3-(triethoxysilyl)propyloctadecyldimethyl ammonium chloride.
Career Highlights
Whalen is associated with The Dow Chemical Company, where he has been able to leverage his expertise in microbiology and antibiotic research. His innovative approaches have contributed to advancements in animal health and agricultural practices.
Collaborations
Throughout his career, Whalen has collaborated with notable colleagues, including Gregory L. Swartz and Lisa J. Rheaume. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Joseph W. Whalen's contributions to antibiotic development and animal health demonstrate his commitment to innovation in the field. His patents reflect a dedication to improving agricultural practices and addressing bacterial challenges.